For treatment of: Ergoferon antiviral immune system.Ergoferon antiviral
- For the treatment of internal organs: immune system
- Appointment: prevention of flu, SARS, treatment of flu
- Indications for use:
Prevention and treatment of influenza A and B (including "avian" influenza A/H5N1 and "swine" influenza A/H1N1).
Prevention and treatment of acute respiratory viral infections caused by parainfluenza virus, adenovirus, respiratory syncytial virus, and coronavirus.
Prevention and treatment of herpesvirus infections (labial herpes, ophthalmic herpes, genital herpes, chickenpox, herpes zoster, infectious mononucleosis).
Prevention and treatment of acute intestinal infections of viral etiology (caused by calicivirus, adenovirus, coronavirus, rotavirus, enteroviruses).
Prevention and treatment of enterovirus and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis.
Use in the complex therapy of bacterial infections (pseudotuberculosis, whooping cough, yersiniosis, pneumonia of various etiologies, including those caused by atypical pathogens (M. pneumoniae, C. Pneumoniae, Legionella spp)); prevention of bacterial complications of viral infections, prevention of superinfections.
Increased individual sensitivity to the components of the medication.
Active substance: antibodies to human gamma interferon affinity purified – 0.006 g, antibodies to histamine affinity purified – 0.006 g, antibodies to CD4 affinity purified – 0.006 g.
Excipients: lactose monohydrate – 0.267 g, microcrystalline cellulose – 0.03 g, magnesium stearate – 0.003 g.